¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"slow-reacting substance of anaphylaxis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® anaphylaxis ÇÑ±Û ¾Æ³ªÇʶô½Ã½º, °ú¹ÎÁõ
¼³¸í   
  ¾Æ³ªÇʶô½Ã½º¶ó´Â ¸»Àº Á¦ 1Çü °ú¹Î¹ÝÀÀ°ú °°Àº ¸»·Î ¿Ü°èÀÇ ¹°Áú¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô Ç×ÁøµÇ¾î Àִ º´ÀûÀΠ»óŸ¦ ¸»ÇÑ´Ù. ¸é¿ªÀ̶õ ¿ÜºÎ¹°Áú¿¡ ´ëÇÑ ¹æ¾î¸¦ ¸ñÀûÀ¸·Î Çϴ ¼¼Æ÷µéÀǠȰµ¿À» ÀǹÌÇϸç, ¿©±â¿¡´Â Ç×üÀÇ Çü¼º, ¼¼Æ÷µéÀÇ Æ÷½ÄÀÛ¿ë(¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ¸é¿ª±â´ÉÀ» Çϴ ¼¼Æ÷°¡ Àâ¾Æ¸Ô´Â °Í)µîÀÌ Æ÷ÇԵȴÙ. Ç×üÀÇ Çü¼ºÀº ¿ÜºÎ·ÎºÎÅÍ µé¾î¿Â ¹°ÁúÀ» ¿ì¼± Å«Æ÷½Ä¼¼Æ÷ µîÀÌ Æ÷½ÄÀ» Çϰí À̰Ϳ¡ ´ëÇÑ Á¤º¸¸¦ T-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϰí T-¸²ÇÁ±¸´Â ÀÌ Á¤º¸¸¦ Ã³¸®ÇÏ¿© Áý¾àµÈ Á¤º¸¸¦ B-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϸç ÀÌ ¼¼Æ÷·Î ÇÏ¿©±Ý ±× ¹°Áú ¿¡ ´ëÇÑ Ç×ü¸¦ »ý¼ºÇϰԠÇÑ´Ù. Ç×ü´Â ¿ÜºÎÀÇ ¹°Áú°ú Á¤È®È÷ °áÇÕÇÏ¿© ¿ÜºÎÀÇ ¹°ÁúÀǠȰ¼ºÈ­¸¦ ¾ø¾Ö´Â ¹°ÁúÀÌ´Ù. ÀÌ·¸°Ô Çü¼ºµÈ Ç×üÁß¿¡¼­ IgE¿¡ ºÎÂøµÉ ¼ö ÀÖ´Â, Áï À̹̠Ç×ü IgE°¡ Çü¼ºµÈ(ÀÌ·¸°Ô µÇ±â À§Çؼ­´Â ±× ¹°ÁúÀÌ ÀÌÀü¿¡ ÇÑ ¹ø ¸ö¼Ó¿¡ µé¾î ¿Ô¾î¾ß ÇÑ´Ù) ¹°ÁúÀÌ È÷½ºÅ¸¹Î µîÀÇ ¿©·¯ ¹°ÁúÀÌ ³ª¿À°Ô µÇ°í ÀÌ·± ¹°Áúµé¿¡ ÀÇÇØ¼­ »ý±â´Â ¿©·¯ °¡Áö ½Åü¿¡ ÇطοÝÀÀÀÌ »ý°Ü³­´Ù. ±×·¡¼­ ÇÊ¿ä ÀÌ»óÀ¸·Î °ú¹ÎÇÑ ÀÌ·¯ÇÑ ÇüÅÂÀÇ ¸é¿ªÀÛ¿ëÀ» °ÅÄ¡´Â ¹ÝÀÀÀ» ¾Æ´ÏÇʶô½Ã½º¶ó ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • exercise-induced anaphylaxis
    ¿îµ¿À¯¹ß¾Æ³ªÇʶô½Ã½º
  • generalized anaphylaxis
    Àü½Å¾Æ³ªÇʶô½Ã½º
  • local anaphylaxis
    ±¹¼Ò¾Æ³ªÇʶô½Ã½º
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
  • cortical substance
    °ÑÁú, ÇÇÁú
  • crystalline substance
    °áÁ¤¹°Áú
  • cement substance
    Á¢ÇÕÁú, ½Ã¸àÆ®¹°Áú
  • chromophil substance
    È£»ö¼Òü, »ö¼Òģȭ¹°Áú
  • depressor substance
    °¨¾Ð¹°Áú
  • ferromagnetic substance
    °­ÀÚ¼º¹°Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • substance
    ¹°Áú, Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
  • odoriferous substance
    Çâ·á
  • pyrogenic substance
    ¹ß¿­¹°Áú
  • reaction substance
    ¹ÝÀÀ¹°Áú
  • reserve substance
    ÀúÀå¹°Áú
  • spongy substance
    ÇØ¸éÁú
  • toxic substance
    µ¶¼º¹°Áú
  • substance withdrawal
    ¹°Áú±Ý´Ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • exercise-induced anaphylaxis
    ¿îµ¿À¯µµ¾Æ³ªÇʶô½Ã½º
  • generalized anaphylaxis
    Àü½Å¾Æ³ªÇʶô½Ã½º
  • local anaphylaxis
    ±¹¼Ò¾Æ³ªÇʶô½Ã½º
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
  • accelerans substance
    ÃËÁø¹°Áú
  • accessory food substance
    ºÎ¿µ¾ç¹°Áú
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º¹°Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú
  • antithyroid substance
    Ç×¹æÆÐ»ù¹°Áú, Ç×°©»ó»ù¹°Áú
  • antiyeast substance
    Ç×È¿¸ð¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ground substance amorphous substance
    ¹«ÇüÁú
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã.
  • anaphylaxis
    ¾Æ´ÏÇʶô½Ã
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • anaphylaxis
    °ú¹ÎÁõ, ¾Æ³ªÇʶô½Ã½º
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º, °ú¹ÎÁõ(ΦÚÂñø)
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º.
  • anaphylaxis,arachidonic acid metabolitesin
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ß« ÓÛÞóÚªòõ)
  • antiserum anaphylaxis
    Ç×Ç÷û¾Æ³ªÇʶô½Ã.
  • antiserum anaphylaxis
    Ç×Ç÷û¾Æ³ªÇʶô½Ã½º.
  • generalized anaphylaxis
    Àü½Å¾Æ³ªÇʶô ½Ã½º.
  • generalized anaphylaxis
    Àü½Å ¾Æ³ªÇʶô½Ã½º
  • heterologous anaphylaxis
    ÀÌÁ¾¾Æ³ªÇʶô½Ã.
  • histamine, anaphylaxis
    È÷½ºÅ¸¹Î, ¾Æ³ªÆÈ¶ô½Ã¼º
  • homologous anaphylaxis
    µ¿Á¾(ÔÒðú)¾Æ³ªÇʶô½Ã.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • slow reacting substance of anaphylaxis
    ¾Æ³ªÇʶô½Ã½º Áö¿¬¹ÝÀÀ¹°Áú
  • ground substance amorphous substance
    ¹«ÇüÁú
  • anaphylaxis
    °ú¹ÎÁõ, ¾Æ³ªÇʶô½Ã½º
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º, °ú¹ÎÁõ(ΦÚÂñø)
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º.
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã.
  • anaphylaxis
    ¾Æ´ÏÇʶô½Ã
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • anaphylaxis,arachidonic acid metabolitesin
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ß« ÓÛÞóÚªòõ)
  • antiserum anaphylaxis
    Ç×Ç÷û¾Æ³ªÇʶô½Ã.
  • antiserum anaphylaxis
    Ç×Ç÷û¾Æ³ªÇʶô½Ã½º.
  • cutaneous anaphylaxis
    ÇǺξƳªÇʶô½Ã.
  • cutaneous anaphylaxis
    ÇǺξƳªÇʶô½Ã½º
  • exercise-induced anaphylaxis
    ¿îµ¿ À¯µµ¼º À̳ªÇʶô½Ã½º
  • generalized anaphylaxis
    Àü½Å¾Æ³ªÇʶô ½Ã½º.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ground substance [Amorphous substance]
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ±âÁú
  • Lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£Áú¿ÜÃøºÎ
  • Proper substance of cornea
    °¢¸·°íÀ¯Áú
    [¿¾ ¿ë¾î] °¢¸·°íÀ¯Áú
  • Proper substance of sclera
    °ø¸·°íÀ¯Áú
    [¿¾ ¿ë¾î] °ø¸·°íÀ¯Áú
  • Muscular substance
    ±ÙÀ°Áú
    [¿¾ ¿ë¾î] ±ÙÁú
  • Chromophilic substance [Nissl body]
    ´Ö½½¼Òü
    [¿¾ ¿ë¾î] ´Ö½½¼Òü
  • Posterior perforated substance
    µÚ°üÅëÁú
    [¿¾ ¿ë¾î] ÈÄÀ¯°øÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ±âÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] »ó¾ÆÁú±âÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ¿¬°ñ±âÁú
  • White substance
    ¹é»öÁú
    [¿¾ ¿ë¾î] ¹éÁú
  • Cortical substance
    »À°ÑÁú
    [¿¾ ¿ë¾î] ÇÇÁú
  • Fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
    [¿¾ ¿ë¾î] À¯¼¶À¯¼ÒÁú
  • Reticular substance
    ¼¼¸ÁÁú
    [¿¾ ¿ë¾î] ¼¼¸ÁÁú
  • Intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
    [¿¾ ¿ë¾î] ¼¼Æ÷°£Áú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active anaphylaxis
    Ȱ¼º(üÀàõ)¾Æ³ªÇʶô½Ã½º
  • aggregate anaphylaxis
    ÀÀÁý(ëêó¢)¾Æ³ªÇʶô½Ã½º
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • cytotoxic anaphylaxis
    ¼¼Æ÷µ¶¼º(á¬øàÔ¸àõ) ¾Æ³ªÇʶô½Ã½º
  • cytotropic anaphylaxis
    Çâ¼¼Æ÷(ù÷á¬øà) ¾Æ³ªÇʶô½Ã½º
  • passive anaphylaxis
    ¼öµ¿(áôÔÑ) ¾Æ³ªÇʶô½Ã½º
  • C substance
    C ¹°Áú(Úªòõ)
  • ferredoxin reducing substance
    Æä¸®µ¶½Å ȯ¿ø ¹°Áú(ü½êªÚªòõ)
  • ground substance
    ¹ÙÅÁ¹°Áú(Úªòõ)
  • pectic substance
    Æåƾ ¹°Áú(Úªòõ)
  • photodynamic substance
    ±¤¿ªÇÐ ¹°Áú(Úªòõ)
  • queen substance
    ¿©¿ÕºÀ(Ò³èÝÜð) ¹°Áú(Úªòõ)
  • rabbit aorta contracting substance
    Åä³¢ ´ëµ¿¸Æ ¼öÃ๰Áú(ÓÞÔÑØæâ¥õêÚªòõ)
  • slow-reacting substance
    ¿Ï¼Ó(èÐáÜ) ¹ÝÀÀ¹°(ÚãëëÚª)
  • substance P
    P ¹°Áú(Úªòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã, °ú¹ÎÁõ
  • anterior perforated substance
    ÀüÀ¯°ø¹°Áú
  • ferromagnetic substance
    öÀÚ¼ºÃ¼, °­ÀÚ¼ºÃ¼
  • gray substance
    ȸ»öÁú
  • nerve transmitter substance
    ½Å°æÀü´Þ¹°Áú
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • radioactive substance
    ¹æ»ç¼º¹°Áú
  • substance
    ¹°Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SRS-A Slow Reacting Substance of Anaphylaxis
SRSA, SRS-A slow-reacting substance of anaphylaxis
MIS management information system; medical information service; meiosis-inducing substance; minimally in...
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
BK-A basophil kallikrein of anaphylaxis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SRS-A Slow Reacting Substance of Anaphylaxis
ACA Active cutaneous anaphylaxis
IA Idiopathic Anaphylaxis
PCA Passive Cutaneous Anaphylaxis
ASA active systemic anaphylaxis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • heterologous anaphylaxis
    ÀÌÁ¾ ¾Æ³ªÇʶô½Ã
  • accelerans substance
    ÃËÁø¹°Áú
    ½ÉÀå ½Å°æ ÀÛ¿ëÀÇ ¾×ü Àüµµ¿¡ À־, ÃËÁø ½Å°æÀ» ÀÚ±ØÇÔÀ¸·Î½á »ý±â´Â ½É¹Ú Áõ°¡¼º À§¿îµ¿ ¾ïÁ¦¼º ¹°Áú.
  • accessory food substance
    ºÎ¿µ¾ç¹°
  • accessory growth substance
    ¹ßÀ° º¸Á¶ ¹°Áú
    ¹ßÀ°À» Çϴµ¥ º¸Á¶µÇ´Â ¹°Áú.
  • agglutinable substance
    ÀÀÁý¼º ¹°Áú
  • anti-intercellular substance antibody
    Ç×¼¼Æ÷°£ ¹°Áú Ç×ü
  • ascending substance P
    »óÇà P ¹°Áú
  • bone inducing substance
    °ñ Çü¼º À¯µµ ÀÎÀÚ
  • bone substance
    °ñÁú
  • cement substance
    Á¢ÇÕ ¹°Áú
    µÎ °³ÀÇ Ç¥¸éÀ» °ß°íÇÏ°Ô Á¢ÇÕÇÏ´Â ¹°Áú.
  • coagualtion-active substance
    ÀÀ°í Ȱ¼º ¹°Áú
  • corrosive substance
    ºÎ½Ä ¹°Áú, ºÎ½Ä¼º ¹°Áú
  • cytotoxic substance
    ¼¼Æ÷ µ¶, ¼¼Æ÷µ¶¼Ò
    µ¿ÀǾî=cytotoxin.
  • endobiotic substance
    ³»»ýÀû ¹°Áú
  • ferromagnetic substance
    öÀÚ¼º ü, °­ÀÚ¼º ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
slow reacting substance of anaphylaxis <immunology> Potent bronchoconstrictor and inflammatory agent released by mast cells, an important mediator of allergic bronchial asthma.
A mixture of three leukotrienes (LTC4 mainly, LTD4 and LTE4)
(18 Nov 1997)
active anaphylaxis Reaction following inoculation of antigen in a subject previously sensitised to the specific antigen, in contrast to passive anaphylaxis.
(05 Mar 2000)
aggregate anaphylaxis <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism.
<immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses.
Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension.
See: hypersensitivity.
(18 Nov 1997)
anaphylaxis <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism.
<immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses.
Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension.
See: hypersensitivity.
(18 Nov 1997)
antiserum anaphylaxis A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations.
Synonym: antiserum anaphylaxis.
(05 Mar 2000)
generalised anaphylaxis The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen).
See: anaphylactic shock.
Synonym: systemic anaphylaxis.
(05 Mar 2000)
passive anaphylaxis A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations.
Synonym: antiserum anaphylaxis.
(05 Mar 2000)
passive cutaneous anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. Pca is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.
(12 Dec 1998)
passive cutaneous anaphylaxis test An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions.
(05 Mar 2000)
reversed anaphylaxis An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen.
Synonym: reversed anaphylaxis.
(05 Mar 2000)
reversed passive anaphylaxis An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen.
Synonym: reversed anaphylaxis.
(05 Mar 2000)
pharmacologic mediators of anaphylaxis Substances released from mast (and other) cells by the reaction of antigen and specific homocytotropic antibody on their surfaces; they include histamine, slow-reacting substance of anaphylaxis (SRS-A), bradykinin, and (in some species of animals) serotonin.
(05 Mar 2000)
chronic anaphylaxis A haemorrhagic and necrotizing inflammation developing in the ileum (and also the colon) of sensitised dogs when they are fed a second dose of the sensitizing material.
Synonym: chronic anaphylaxis.
(05 Mar 2000)
slow-reacting factor of anaphylaxis Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules.
Compare: peptidyl leukotrienes.
Synonym: slow-reacting factor of anaphylaxis.
(05 Mar 2000)
systemic anaphylaxis The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen).
See: anaphylactic shock.
Synonym: systemic anaphylaxis.
(05 Mar 2000)
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 1 ÆäÀÌÁö: 1
  • slow-reacting substance of anaphylaxis - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    °ú¹ÎÁõ(°ú´Ô¼º)ÀÇ;¾Æ³ªÇʶô½Ã½ºÀÇ
  • in substance
    »ç½Ç»ó,½ÇÁúÀûÀ¸·Î
  • substance
    ¹°Áú,½Çü,º»Ã¼,º»Áú,³»¿ë,¾Ë¸ÍÀÌ,¼ºÁú,Àç»ê,ÀÚ»ê
  • the substance
    ´ëºÎºÐ
  • controlled substance
    ±ÔÁ¦ ¾à¹°(¼ÒÁö¹× »ç¿ëÀÌ ±ÔÁ¦µÇ´Â ¾à¹°)
  • substance
    ¹°Áú;(¾î¶² Á¾·ùÀÇ)¹°°Ç;½Çü;º»Áú;¿äÁö;½ÇÁú;Àç»ê;in ~ ´ëü·Î;½ÇÁúÀûÀ¸·Î;»ç½Ç»ó
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á